- Ozempic's published list price is roughly $1,027 for a one-month pen, so the cash cost without insurance is well over $900 a month — verify the current figure on NovoCare.
- Ozempic (semaglutide) is FDA-approved for type 2 diabetes; Wegovy is the semaglutide product approved for weight management, which is why off-label weight-loss use is often not covered.
- Novo Nordisk's savings card can lower copays for people with commercial (non-government) insurance; it does not apply to Medicare or Medicaid, and a patient assistance program may help qualifying uninsured patients.
- Discount cards like GoodRx offer limited savings on a brand-only drug with no generic, so the biggest levers are insurance coverage for diabetes and manufacturer programs.
- Compounded semaglutide is winding down as the FDA-declared shortage has resolved, and counterfeit pens are a real risk — use a licensed pharmacy and your prescriber.
- Ozempic carries a boxed warning about thyroid C-cell tumors seen in rodents; it is not for people with a personal or family history of medullary thyroid carcinoma or MEN 2 — decisions are prescriber-directed.
The Ozempic cost without insurance is one of the most searched healthcare-pricing questions in the country, and for good reason. Novo Nordisk’s own NovoCare site lists Ozempic at roughly $1,027 for a one-month pen, so paying cash for a single prefilled pen puts this popular GLP-1 medication out of reach for many people who could benefit from it. List prices change, so treat that number as a current-as-of-this-writing figure and verify it on NovoCare before you rely on it.
Ozempic (semaglutide) is FDA-approved to treat type 2 diabetes, and it also carries an approved indication to reduce the risk of major cardiovascular events in adults with type 2 diabetes and known heart disease. It is widely prescribed off-label for weight loss, which is a key reason coverage can be inconsistent — the semaglutide product approved specifically for chronic weight management is Wegovy, not Ozempic. Manufactured by Novo Nordisk, semaglutide has become one of the best-selling medicines in the world, but the price remains a major barrier. This costs guide breaks down Ozempic pricing and practical, prescriber-directed ways to save. It is general education, not medical advice, and nothing here is dosing guidance.
Ozempic Retail Price Without Insurance in 2026
Without insurance or a savings program, Ozempic’s list price is the same across its dosage strengths because it is priced per pen rather than per milligram. According to NovoCare, the recent published list price is about $1,027.51 for a one-month supply, regardless of whether the pen delivers the 0.25/0.5 mg, 1 mg, or 2 mg strength. What you actually pay at a given pharmacy can differ from the list price depending on the pharmacy’s markup and any discounts applied.
| Dosage strength | Supply duration | Approximate list price (verify current) |
|---|---|---|
| 0.25 mg or 0.5 mg pen | ~4 weeks | About $1,000+ |
| 1 mg pen | ~4 weeks | About $1,000+ |
| 2 mg pen | ~4 weeks | About $1,000+ |
At roughly $1,000+ per month, the annual cash cost of Ozempic without insurance runs well over $12,000. That makes it one of the most expensive commonly prescribed medications in the United States, comparable in price to other GLP-1 receptor agonists like semaglutide (Wegovy) and tirzepatide (Mounjaro). Prices at online and big-box pharmacies can differ modestly from chain drugstores, but because Ozempic has no generic, the differences are usually small relative to the total.
Ozempic Cost With Insurance
Insurance coverage for Ozempic depends heavily on the indication it is prescribed for and the specifics of your plan:
- Type 2 diabetes with commercial insurance: Most plans cover Ozempic for diabetes, often with copays in the tens to low hundreds of dollars a month; Novo Nordisk’s savings card can reduce that further for eligible commercially insured patients.
- Weight loss (off-label) with commercial insurance: Coverage is inconsistent. Many insurers will not cover Ozempic for weight management because it is not FDA-approved for that use. Wegovy (also semaglutide) is the weight-loss-specific product, though obesity coverage varies widely by plan too.
- Medicare Part D: Ozempic is covered for diabetes under many Part D formularies. Medicare Part D now has an annual out-of-pocket cap that helps limit total spending; confirm the current cap amount, as it is set in law and adjusts over time. Medicare does not cover drugs used solely for weight loss.
- Medicaid: Coverage varies by state and usually applies to the diabetes indication, often with prior authorization or step therapy.
If you are specifically seeking coverage for weight management, ask your prescriber about a Wegovy prescription, which is the product approved for that indication.
How to Save Money on Ozempic Without Insurance
If you are facing the full Ozempic cost without insurance, several programs and strategies may reduce your out-of-pocket expense. All of them work best when coordinated with your prescriber and a licensed pharmacy.
Novo Nordisk Savings Card
Novo Nordisk offers an Ozempic savings offer for patients with commercial or employer insurance that can lower monthly copays, subject to program terms and maximums. Importantly, this savings card does not apply to patients covered by Medicare, Medicaid, or other government programs. Check current eligibility and savings amounts on the official Ozempic/NovoCare website, since terms change.
Patient Assistance Program
Novo Nordisk’s patient assistance program may provide Ozempic at no cost to qualifying patients who are uninsured or underinsured and meet income requirements. Your prescriber’s office can help you apply and confirm the current criteria.
NovoCare Pharmacy and Self-Pay Options
Novo Nordisk has expanded direct-to-patient and cash-pay pathways through NovoCare Pharmacy, which some self-pay patients use to obtain the branded product at a defined price with home delivery. Availability and pricing depend on eligibility and change over time, so verify the current offer before assuming a specific cost.
Prescription Discount Cards
Services like GoodRx and RxSaver sometimes offer coupons for Ozempic, but savings on a brand-only drug with no generic tend to be limited compared with what manufacturer programs or diabetes insurance coverage can do. It can still be worth comparing prices across pharmacies, but do not expect a discount card to bring a $1,000 drug down to pocket change.
Compounded Semaglutide: Winding Down
During the period when the FDA listed semaglutide in shortage, some compounding pharmacies sold semaglutide injections at lower prices. That landscape has changed: the FDA has declared the semaglutide shortage resolved, which limits the legal basis for large-scale compounding, and the agency has repeatedly warned about the safety, sterility, and dosing accuracy of compounded and counterfeit semaglutide. Fake “Ozempic” pens have been found in the U.S. supply chain. Because of these risks, obtain semaglutide only through a licensed pharmacy with a valid prescription, and discuss any compounded option with your prescriber first.
International Pharmacies
Ozempic is priced lower in some other countries, and a few patients look abroad, but personal importation is generally prohibited by the FDA and quality cannot be guaranteed. This route carries legal and safety risks and is not a recommendation.
Ozempic vs. Other GLP-1 Medications: Price Comparison
If the Ozempic cost without insurance is too high, comparing alternatives with your doctor may surface a more affordable or better-covered option. All list prices below are approximate and change frequently — verify current pricing before deciding.
| Medication | Approx. monthly list price (verify) | FDA-approved for |
|---|---|---|
| Ozempic (semaglutide injection) | ~$1,000+ | Type 2 diabetes; CV risk reduction in T2D |
| Wegovy (semaglutide 2.4 mg) | ~$1,300+ | Chronic weight management |
| Mounjaro (tirzepatide) | ~$1,000+ | Type 2 diabetes |
| Zepbound (tirzepatide) | ~$1,000+ | Chronic weight management |
| Rybelsus (oral semaglutide) | ~$1,000+ | Type 2 diabetes |
| Trulicity (dulaglutide) | ~$900+ | Type 2 diabetes |
All GLP-1 receptor agonists sit in a similar high price range, but insurance coverage and manufacturer savings programs differ by product. For a detailed comparison, see our guide on semaglutide pricing. Which medicine is right for you is a clinical decision for your prescriber, not something to choose on price alone.
Why Is Ozempic So Expensive?
- Patent protection: Novo Nordisk holds patents on semaglutide that prevent generic competition, so no low-cost generic Ozempic is expected in the near term.
- Manufacturing complexity: GLP-1 medicines are made through complex processes that cost more than traditional small-molecule pills.
- High demand: Surging demand, driven largely by weight-loss interest, has kept pricing high and at times strained supply.
- Limited price negotiation so far: The Inflation Reduction Act created Medicare drug price negotiation. Semaglutide products (Ozempic/Rybelsus/Wegovy) have been named among drugs selected for a negotiation cycle, but any negotiated price applies only to Medicare and takes effect on a future date — verify the current status and timing, as this program is rolling out in stages.
Will Ozempic Get Cheaper?
- Medicare negotiation: A negotiated Medicare price for semaglutide could lower costs for Medicare beneficiaries once it takes effect and may influence the broader market; confirm the effective date and terms.
- More competition: New GLP-1 and combination drugs entering the market could pressure prices over time.
- Eventual generics/biosimilars: Once patents lapse, competition would likely reduce prices, but that is years away.
- Policy attention: Ongoing scrutiny of drug pricing may prompt additional measures affecting semaglutide and similar medicines.
Safety Notes You Should Know
Ozempic carries a boxed warning about thyroid C-cell tumors observed in rodent studies; it is not recommended for people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Serious potential side effects can include pancreatitis, gallbladder problems, kidney problems from dehydration, and (per FDA labeling updates) reports related to a risk of aspiration during anesthesia or deep sedation, so tell any surgeon or anesthesiologist that you take a GLP-1 drug. Common side effects include nausea, vomiting, diarrhea, and constipation. Starting, stopping, switching, or adjusting a GLP-1 medication is a decision for your prescriber — this article does not provide dosing instructions.
Frequently Asked Questions
Can I get Ozempic for free?
Possibly, through Novo Nordisk’s patient assistance program, which may provide Ozempic at no cost to qualifying uninsured or underinsured patients who meet income requirements. Your prescriber’s office can help you apply, and you should confirm the current criteria directly with the program.
Is compounded semaglutide the same as Ozempic?
No. Compounded semaglutide contains the same active ingredient but is not the FDA-approved, Novo Nordisk-manufactured product, and it may differ in purity, potency, and sterility. With the FDA-declared shortage resolved, large-scale compounding is winding down, and the FDA has warned about compounded and counterfeit products. Use a licensed pharmacy and talk to your prescriber.
Does Ozempic cost the same as Wegovy?
Not usually. Wegovy generally lists higher than Ozempic. Wegovy is a higher-dose semaglutide product approved for chronic weight management, while Ozempic is approved for type 2 diabetes. Coverage patterns differ too, so verify both prices and your plan’s rules.
Can I switch from Ozempic to a cheaper medication?
Talk to your doctor if cost is prohibitive. For type 2 diabetes, generic metformin is inexpensive and remains a first-line treatment for blood-sugar control, though it does not produce the same weight loss. Other GLP-1 options or combination approaches may also be worth discussing. Any switch is a clinical decision.
Is Ozempic covered by all insurance plans?
No. Coverage varies by plan and by indication. Most commercial plans and many Medicare Part D formularies cover Ozempic for type 2 diabetes; coverage for off-label weight loss is much less common. Always verify coverage with your insurer before filling a prescription.
Final Takeaway
The Ozempic cost without insurance is roughly $1,000 or more per month at its published list price, making it a significant financial commitment for uninsured patients — verify the current figure on NovoCare, since list prices change. With insurance for a diabetes indication, out-of-pocket costs can be much lower. To reduce costs, explore the Novo Nordisk savings card (commercial insurance only), the patient assistance program, and NovoCare self-pay options, and be wary of compounded or counterfeit products now that the shortage has resolved. Discuss alternatives like other semaglutide formulations or Wegovy for weight management with your physician, and remember that medication choices and dosing are prescriber-directed. For more, visit our costs guide.
Ozempic’s list price is about $1,027 for a one-month pen (well over $900), but prices, savings programs, and coverage change often — verify current details with NovoCare, your insurer, and your pharmacy. This article is general education, not medical advice, and it contains no dosing instructions. Ozempic (semaglutide) is FDA-approved for type 2 diabetes; Wegovy is the weight-loss product. Do not start, stop, switch, or adjust a GLP-1 medication on your own — those are prescriber decisions. Ozempic carries a boxed warning about thyroid C-cell tumors and is not for people with a personal or family history of medullary thyroid carcinoma or MEN 2. Use only a licensed pharmacy, given the risk of counterfeit and compounded products.
Sources
- NovoCare / Novo Nordisk — Ozempic list price (about $1,027.51 per pen/package), commercial-insurance savings offer, patient assistance program, and NovoCare Pharmacy self-pay option (verify current pricing and terms)
- U.S. Food and Drug Administration (FDA) — Ozempic (semaglutide) approved indications for type 2 diabetes and cardiovascular risk reduction; thyroid C-cell boxed warning; warnings on compounded and counterfeit semaglutide; resolution of the semaglutide shortage
- MedlinePlus (U.S. National Library of Medicine) — semaglutide (Ozempic) uses, safety, and side-effect information
- Medicare.gov / CMS — Medicare Part D out-of-pocket cap context and Inflation Reduction Act drug price negotiation program status (verify current amounts and timing)